IMF INTERNATIONAL MYELOMA FOUNDATION
DEAD

Serial Number

86522703

Owner

International Myeloma Foundation

Attorney

Olivia Goodkin

First Use Date

Jul 17, 2014

Filing Date

Feb 3, 2015

Add to watchlist:

No watchlists yet
View on USPTO

IMF INTERNATIONAL MYELOMA FOUNDATION Trademark

Serial Number: 86522703 • Registration: 4782056

IMF INTERNATIONAL MYELOMA FOUNDATION is a trademark filed by International Myeloma Foundation on February 3, 2015. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

International Myeloma Foundation (85 trademarks)

Suite 206
North Hollywood, CA 91607

Entity Type: 99

Trademark Details

Filing Date

February 3, 2015

Registration Date

July 28, 2015

First Use Anywhere

July 17, 2014

First Use in Commerce

July 17, 2014

Published for Opposition

May 12, 2015

Cancellation Date

February 4, 2022

Goods & Services

Arranging and conducting educational conferences; Conducting workshops and seminars in the field of myeloma research, diagnosis and treatment; Education services, namely, providing seminars, conferences, workshops and symposia in the field of myeloma research, diagnosis and treatment; Electronic publishing services, namely, publication of text and graphic works of others on DVD, CD and online featuring information about myeloma

Charitable fundraising; Providing grants for research in the field of myeloma

Developing quality control standards for the treatment and care of myeloma patients; Development of voluntary standards for the treatment and care of myeloma patients

Association services, namely, promoting the public interest and awareness in cancer research and education; Association services, namely, promoting public awareness of myeloma research, diagnosis and treatment, and the need for access to a broad range of approved and medically-accepted anticancer regimens; Promoting awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of myeloma research, diagnosis and treatment; Public advocacy to promote awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens

Downloadable fact sheets in the field of myeloma research, diagnosis and treatment; Downloadable podcasts in the field of myeloma research, diagnosis and treatment; Downloadable webcasts in the field of myeloma research, diagnosis and treatment; Downloadable webinars in the field of myeloma research, diagnosis and treatment; Downloadable written articles in the field of myeloma research, diagnosis and treatment; Electronic publications, namely, newsletters, journals, manuals and pamphlets featuring information on myeloma research, diagnosis and treatment recorded on computer media

Printed educational materials in the field of myeloma research, diagnosis and treatment

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 4, 2022 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 28, 2020 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2018 TCCA
REGISTERED-PRINCIPAL REGISTER
Jul 28, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2015 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 4, 2015 PREV
ASSIGNED TO LIE
Apr 4, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 11, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 11, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 11, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 11, 2015 CNEA
ASSIGNED TO EXAMINER
Mar 11, 2015 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 13, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2015 NWOS
NEW APPLICATION ENTERED
Feb 6, 2015 NWAP